ArticleAmerican heart journal plus : cardiology research and practice2022

Deprescribing in type 2 diabetes and cardiovascular disease: Recommendations for safe and effective initiation of glucagon-like peptide-1 receptor agonists in patients on insulin therapy.

Elizabeth Van Dril et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.